Connor, Clark & Lunn Investment Management »

Arbutus Biopharma shares owned by Connor, Clark & Lunn Investment Management

Quarter-by-quarter ownership of Arbutus Biopharma (ABUS) shares owned by Connor, Clark & Lunn Investment Management from 13F filings

Historical chart of Connor, Clark & Lunn Investment Management investment in Arbutus Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Arbutus Biopharma held by Connor, Clark & Lunn Investment Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arbutus Biopharma by Connor, Clark & Lunn Investment Management

Quarter filed Position value Share count Share price at filing
2026-03-31 $116k 26k 4.50
2024-03-31 $34k 13k 2.58
2022-09-30 $173k 91k 1.91

More positions owned by Connor, Clark & Lunn Investment Management

Rbc Cad (RY)
Agnico (AEM)
Toronto Dominion Bk Ont Com New (TD)
Suncor Energy (SU)
Enbridge (ENB)
NVIDIA Corporation (NVDA)
Cibc Cad (CM)
Tc Energy Corp (TRP)
Apple (AAPL)
Shopify Cl A Sub Vtg Shs (SHOP)
Bk Nova Cad (BNS)
Invesco Exch Traded Fd Tr Ii Purbta Msci Us (PBUS)
Canadian Pacific Kansas City (CP)
Microsoft Corporation (MSFT)
Amazon (AMZN)

View all positions for Connor, Clark & Lunn Investment Management

Top funds holding Arbutus Biopharma

Morgan Stanley
Two Seas Capital
Whitefort Capital Management
BlackRock
Vanguard Group
Vanguard Capital Management
Rubric Capital Management
State Street Corporation
Adage Capital Partners GP
Geode Capital Management
ADAR1 Capital Management
Legal & General Group
Woodline Partners
Leucadia National Corporation
BlackBarn Capital Partners

View all funds holding Arbutus Biopharma